title: Reply from authors re: Apostolos Apostolidis. Male lower urinary tract symptoms: a riddle waiting to be solved. Eur Urol 2013;64:408-10: a rationale for combination antimuscarinic-α-blocker therapy for male lower urinary tract symptoms.
authors.affiliation: Maastricht University Medical Centre, Maastricht, The Netherlands. p.vankerrebroeck@mumc.n
authors.forename: Philip
authors.initials: P
authors.lastname: Van Kerrebroeck
authors.forename: François
authors.initials: F
authors.lastname: Haab
authors.forename: Javier C
authors.initials: JC
authors.lastname: Angulo
authors.forename: Viktor
authors.initials: V
authors.lastname: Vik
authors.forename: Ferenc
authors.initials: F
authors.lastname: Katona
authors.forename: Alberto
authors.initials: A
authors.lastname: Garcia-Hernandez
authors.forename: Monique
authors.initials: M
authors.lastname: Klaver
authors.forename: Klaudia
authors.initials: K
authors.lastname: Traudtner
authors.forename: Matthias
authors.initials: M
authors.lastname: Oelke
mesh_terms: D058668:Adrenergic alpha-1 Receptor Antagonists / Q000008:administration & dosage*; D006801:Humans; D059411:Lower Urinary Tract Symptoms / Q000188:drug therapy*; D008297:Male; D018727:Muscarinic Antagonists / Q000008:administration & dosage*; D011812:Quinuclidines / Q000008:administration & dosage*; D000069464:Solifenacin Succinate; D013449:Sulfonamides / Q000008:administration & dosage*; D000077409:Tamsulosin; D044005:Tetrahydroisoquinolines / Q000008:administration & dosage*; D001743:Urinary Bladder / Q000187:drug effects*; D014555:Urination Disorders / Q000188:drug therapy*; D064804:Urological Agents / Q000008:administration & dosage*
chemical_list: D058668:Adrenergic alpha-1 Receptor Antagonists; D018727:Muscarinic Antagonists; D011812:Quinuclidines; D013449:Sulfonamides; D044005:Tetrahydroisoquinolines; D064804:Urological Agents; D000077409:Tamsulosin; D000069464:Solifenacin Succinate